Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynectics Regulatory News (SNX)

Share Price Information for Synectics (SNX)

Share Price is delayed by 15 minutes
Get Live Data
200.00    0.00 (0.00%)
Bid:
195.00
Ask:
205.00
Spread: 10.00 (5.128%)
Market Cap: £34.01m
SNX Live PriceLast checked at - London Stock Exchange

Intraday Synectics Share Chart

Director/PDMR Shareholding

28 Apr 2017 16:01

RNS Number : 7520D
Synectics PLC
28 April 2017
 

 

28 April 2017

 

 

 

Synectics plc

(the "Company")

Director / PDMR shareholding

 

The Company has been notified that the Trustee of the Company's HMRC Approved Employee Share Acquisition Plan ("ESAP") has purchased 8,038 ordinary shares of 20 pence each in the Company in accordance with the ESAP's rules and on behalf of all ESAP participants.

The shares were purchased on 27 April 2017 at a price of 230 pence each in respect of the six month accumulation period ended on 31 March 2017.

Under the terms of the ESAP, participating members, including employees and certain Directors of the Company, contribute a fixed amount to the Trustee on a monthly basis. The Trustee acquires a number of shares in the Company at the end of the six month accumulation period (the "Period") based upon the contributions made in the Period and determined by the lowest share price at either the beginning of the Period or on the date of purchase. In this instance the share price used for the allocation of the number of shares for ESAP purposes was the price per share at the beginning of the Period (212.5 pence).

As a result of these purchases, the Company has been notified that Paul Webb and Mike Stilwell, Directors and PDMRs of the Company, have each acquired an interest in 423 shares.

Following the share purchase in relation to the ESAP, the interests of Paul Webb and Mike Stilwell in Synectics shares are as follows:

 

Name

Position

Ordinary shares held

Interest in shares in Share Schemes

ResultantTotalInterest

% ofIssuedShare Capital

Paul Webb

Chief Executive

10,000

300,347

310,347

1.74%

Mike Stilwell

Finance Director

6,910

50,647

57,557

0.32%

 

For further information, please contact:

Synectics plc

Tel: +44 (0) 1527 850 080

Richard Brierley, Company Secretary

legalandsecretarial@synecticsplc.com

www.synecticsplc.com

Stockdale Securities

Tel: +44 (0) 20 7601 6100

Tom Griffiths / Henry Willcocks

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHEALLPASSXEFF
Date   Source Headline
30th Mar 20114:35 pmRNSAvailability of Report & Accounts
8th Mar 20117:00 amRNSRe: 2009 Group Executive Shared Ownership Plan
4th Mar 20117:00 amRNSPreliminary Results
1st Feb 201111:06 amRNSNotification of Results
7th Jan 20114:02 pmRNSHolding(s) in Company
4th Jan 20117:00 amRNSAcquisition
21st Dec 201010:45 amRNSHolding(s) in Company
21st Dec 20107:00 amRNSHolding(s) in Company
16th Dec 20107:00 amRNSChange of Adviser
6th Dec 20107:00 amRNSPost Year End Trading Update
27th Jul 20107:00 amRNSInterim Results
3rd Feb 20107:00 amRNSInterim Results
21st Jan 201010:36 amRNSContract Win
15th Jan 20102:59 pmRNSREPLACEMENT: Notice of Results
15th Jan 201010:35 amRNSNotice of Results
11th Nov 200910:59 amRNSResult of AGM
5th Nov 20097:00 amRNSTrading Update
9th Sep 20097:00 amRNSPreliminary Results
16th Jun 20097:00 amRNSStructural and Strategic Reorganisation
4th Feb 20097:00 amRNSInterim Results
16th Jan 200912:06 pmRNSNotification of Results
3rd Sep 20087:00 amRNSPreliminary Results
6th Feb 20087:01 amRNSInterim Results
16th Jan 20087:00 amRNSNotification of Results
6th Dec 20071:09 pmRNSCanc of AIM trading facility
6th Dec 20079:56 amRNSOffer Update
30th Nov 20077:01 amRNSOffer Update
29th Nov 20077:01 amRNSOffer Update
26th Nov 200712:34 pmRNSResult of EGM
23rd Nov 20079:57 amRNSRule 8.1- Synexus
19th Nov 20079:40 amRNSRule 8.1- Synexus
16th Nov 200710:00 amRNSRule 8.1- Synexus
15th Nov 20073:00 pmBUSRule 8.3 - Synexus Clinincal Research Plc
15th Nov 200712:07 pmBUSRule 8.3 - Synexus Clinical Research Plc
15th Nov 20079:16 amRNSRule 8.1- Synexus
14th Nov 20073:21 pmBUSRule 8.3 - Synexus Clinical Research Plc
13th Nov 20073:16 pmBUSRule 8.3 - Synexus Clinical Research Plc
7th Nov 20074:38 pmRNSOffer Document Posted
7th Nov 20077:02 amRNSOffer for Synexus
6th Nov 20079:10 amRNSRule 8.3- Synexus
22nd Oct 200710:46 amRNSHolding(s) in Company
19th Oct 20076:21 pmRNSResponse to price movement
28th Sep 20077:02 amRNSPre Close Statement
5th Sep 20078:33 amRNSBoard Change
5th Sep 20077:01 amRNSPreliminary Results
22nd Aug 20073:17 pmRNSHolding(s) in Company
22nd Aug 200711:19 amRNSAIM RULE 26
15th Jun 20071:26 pmRNSGrant of Options
13th Jun 20077:01 amRNSPreliminary Results
24th May 20074:24 pmRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.